» Articles » PMID: 35163213

Cell Cycle-Dependent Transcription: The Cyclin Dependent Kinase Cdk1 Is a Direct Regulator of Basal Transcription Machineries

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Feb 15
PMID 35163213
Authors
Affiliations
Soon will be listed here.
Abstract

The cyclin-dependent kinase Cdk1 is best known for its function as master regulator of the cell cycle. It phosphorylates several key proteins to control progression through the different phases of the cell cycle. However, studies conducted several decades ago with mammalian cells revealed that Cdk1 also directly regulates the basal transcription machinery, most notably RNA polymerase II. More recent studies in the budding yeast have revisited this function of Cdk1 and also revealed that Cdk1 directly controls RNA polymerase III activity. These studies have also provided novel insight into the physiological relevance of this process. For instance, cell cycle-stage-dependent activity of these complexes may be important for meeting the increased demand for various proteins involved in housekeeping, metabolism, and protein synthesis. Recent work also indicates that direct regulation of the RNA polymerase II machinery promotes cell cycle entry. Here, we provide an overview of the regulation of basal transcription by Cdk1, and we hypothesize that the original function of the primordial cell-cycle CDK was to regulate RNAPII and that it later evolved into specialized kinases that govern various aspects of the transcription machinery and the cell cycle.

Citing Articles

Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.

Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N Signal Transduct Target Ther. 2025; 10(1):11.

PMID: 39800748 PMC: 11734941. DOI: 10.1038/s41392-024-02080-z.


Single-cell RNA sequencing identifies endothelial-derived HBEGF as promoting pancreatic beta cell proliferation in mice via the EGFR-Kmt5a-H4K20me pathway.

Lai F, Zhou K, Ma Y, Lv H, Wang W, Wang R Diabetologia. 2024; .

PMID: 39694915 DOI: 10.1007/s00125-024-06341-y.


Ulp1 Regulates Cell Proliferation Through INO1 in .

Yang J, Zhong B, Yang L, Luo Z, Jia L, Zheng K Genes (Basel). 2024; 15(11).

PMID: 39596659 PMC: 11593471. DOI: 10.3390/genes15111459.


Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2- breast cancer.

Wu S, Xu J, Ma Y, Liang G, Wang J, Sun T Ther Adv Med Oncol. 2024; 16:17588359241282499.

PMID: 39371618 PMC: 11450575. DOI: 10.1177/17588359241282499.


Discovery of Potential Inhibitors of CDK1 by Integrating Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation Studies, and Evaluation of Their Inhibitory Activity.

Teotia V, Jha P, Chopra M ACS Omega. 2024; 9(38):39873-39892.

PMID: 39346877 PMC: 11425824. DOI: 10.1021/acsomega.4c05414.


References
1.
Koivomagi M, Swaffer M, Turner J, Marinov G, Skotheim J . G cyclin-Cdk promotes cell cycle entry through localized phosphorylation of RNA polymerase II. Science. 2021; 374(6565):347-351. PMC: 8608368. DOI: 10.1126/science.aba5186. View

2.
St Amour C, Sanso M, Bosken C, Lee K, Larochelle S, Zhang C . Separate domains of fission yeast Cdk9 (P-TEFb) are required for capping enzyme recruitment and primed (Ser7-phosphorylated) Rpb1 carboxyl-terminal domain substrate recognition. Mol Cell Biol. 2012; 32(13):2372-83. PMC: 3434489. DOI: 10.1128/MCB.06657-11. View

3.
Gorski J, Pathak S, Panov K, Kasciukovic T, Panova T, Russell J . A novel TBP-associated factor of SL1 functions in RNA polymerase I transcription. EMBO J. 2007; 26(6):1560-8. PMC: 1829371. DOI: 10.1038/sj.emboj.7601601. View

4.
Huber A, Bodenmiller B, Uotila A, Stahl M, Wanka S, Gerrits B . Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis. Genes Dev. 2009; 23(16):1929-43. PMC: 2725941. DOI: 10.1101/gad.532109. View

5.
Granovskaia M, Jensen L, Ritchie M, Toedling J, Ning Y, Bork P . High-resolution transcription atlas of the mitotic cell cycle in budding yeast. Genome Biol. 2010; 11(3):R24. PMC: 2864564. DOI: 10.1186/gb-2010-11-3-r24. View